News | Heart Valve Technology | June 19, 2020

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

TAVR is quickly becoming the preferred option for majority of the heart valve patients in India

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts. The company's Hydra TAVR (TAVI) valve gained European CE mark clearance in June 2020.

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device firm Vascular Concepts. The acquisition was completed May 27. 

The company recently gained European CE mark for its Hydra transcatheter aortic valve implantation (TAVI) system in early June 2020.

Vascular Concept will retain its distinct brand and independence and Swaminathan Jayaraman, CEO of Vascular Concept, will continue to manage the operation of the company.

The company has operations in India and Thailand and has more than 200 employees, with two manufacturing sites and two research and development centers. 

It is one of the oldest Indian medical device companies, established in 1988. It has a diversified product portfolio which includes coronary stents, cardiac closure devices, peripheral stents, unique balloon catheters like percutaneous transvenous mitral commissurotomy (PTMC) balloons and transcatheter aortic valve replacement (TAVR) devices.

Vascular Concept developed and launched the Hydra transcatheter aortic valve system, which received Indian regulatory approval in 2020. It is used for the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis. The Hydra TAVR system is a self-expanding supra-annular transcatheter aortic valve, which presents unique design features and similar event rates compared to contemporary devices in separate clinical studies conducted in India and Europe. The TAVI market is growing at about 20% worldwide, Europe and the U.S. being the main markets to date.

“The structural heart segment is a fast-growing segment in cardiovascular industry. We strongly believe that SMT will play a major role within this segment and provide solutions to benefit patients and its wide customer base," explained Dhirajlal Kotadia, chairman of SMT. "Acquisition of Vascular Concepts Group reflects our commitment to become a leader in TAVI and structural heart technologies.”

“We are excited to join hands with SMT, who have a strong leadership in interventional cardiology and has demonstrated aggressive growth in this business," said Jayaraman. "This association will create tremendous market opportunities for both companies to grow in structural heart disease. Vascular Concepts is committed to driving further innovation in the field of structural heart, which can be commercialized together with SMT.”

With an addition of aortic valve to its product categories, SMT advances in its mission to provide best-in-class cardiac care to the healthcare community and patients. 

 

Related SMT Cardiology Device Content:

SMT Hydra TAVR System Receives European CE Mark Approval 

Innovations in Cardiovascular Disease Treatment and the Rising Demand for Stents 

Supraflex Drug-Eluting Stent Superior to Xience in Two-Year Target Vessel Failure

Coronary Stent Market Characterized by New Drug-eluting Stents
 

Related Content

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

News | Cardiovascular Business | September 14, 2020
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular pat
Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant.
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree
Medicare will pay for telehealth virtual doctor visits during the duration of the coronavirus COVID-19 outbreak.
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable bene
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Cardiovascular Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
 Cath Lab Philips Azurion angiography PCI
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures.
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business | November 11, 2019
November 11, 2019 — ECG Management Consultants, a leading U.S.